Fisher Scientific obtains necessary consents to amend 8% notes indenture

By Jennifer Chiou

New York, July 12 - Fisher Scientific International Inc. said holders of a majority of its outstanding 8% senior subordinated notes due 2013 provided the required consents to amend the indenture governing the notes.

The changes will eliminate substantially all of the restrictive covenants and amend certain events of default.

Holders may tender their notes until 5 p.m. ET on July 13, the consent payment deadline, to receive the total consideration, including a $30.00 per $1,000 principal amount consent payment.

Those who tender after the consent deadline but before midnight ET on July 27, unless extended, will not receive the consent payment.

The Hampton, N.H., pharmaceutical and biotechnology service company said investors can no longer withdraw notes tendered.

The company, which tendered for the notes with the proceeds of a $500 million issue of senior subordinated notes due 2015, is offering the present value of the Sept. 1, 2008 redemption price of $1,040 per $1,000 principal amount and the present value of the scheduled interest payments through Sept. 1, 2008, calculating the present value using a discount rate of the 3¾% Treasury due May 15, 2008 plus 50 basis points.

Global Bondholder Services Corp. is the depositary and information agent (866 804-2200 or call collect 212 430-3774). Questions can also be directed to Deutsche Bank Securities Inc. (800 553-2826) or Banc of America Securities LLC (888 292-0070 or call collect 704 388-9217).

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.